Ovarian cancer
Results
Phase 2
This trial looked at gemcitabine as well as paclitaxel and carboplatin for ovarian cancer and primary peritoneal cancer.
Recruitment start: 13 June 2005
Recruitment end: 14 June 2006
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Stanley Kaye
Eli Lilly and Company Limited
National Institute for Health Research Cancer Research Network (NCRN)
Scottish Gynaecological Cancer Trials Group
Last reviewed: 05 May 2011
CRUK internal database number: 667
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
